Scientific research drives innovation at Novartis. Our researchers work to push the boundaries of science, broaden our understanding of diseases and develop novel products with significant benefits for patients. We are focusing on faulty molecular pathways and therapeutic areas where we see the greatest unmet medical need and believe the scientific tools to address these needs are within reach.
The Novartis Institutes for BioMedical Research (NIBR) is the innovation engine of Novartis. Approximately 6 000 scientists and physicians prioritize work based on areas of greatest patient need and scientific understanding of disease.
Strategic alliances with academia and other companies strengthen our pipeline. We carry out research at Novartis locations and at partner institutions around the world:
The Genomics Institute of the Novartis Research Foundation (GNF) - La Jolla, CA, USA
Located in San Diego’s BioMedical research center, GNF is well-known for developing novel technology to drive cutting-edge drug discovery research, identify new biological pathways and discover mechanisms underlying human disease.
Novartis Institutes for BioMedical Research (NIBR) – Emeryville, CA, USA
Located in the San Francisco Bay area, the NIBR Emeryville campus focuses on early discovery and research activities as a hub for infectious disease research, with additional expertise in analytical chemistry, structural and biophysical chemistry, computer-aided drug design, and protein engineering. This facility also houses the Novartis Institute for Tropical Diseases, a drug discovery research institute within NIBR that focuses on novel treatments for neglected tropical diseases.